Virios Therapeutics Inc. (VIRI)
Virios Therapeutics Statistics
Share Statistics
Virios Therapeutics has 1.33M shares outstanding. The number of shares has increased by -95.2% in one year.
Shares Outstanding | 1.33M |
Shares Change (YoY) | -95.2% |
Shares Change (QoQ) | 0% |
Owned by Institutions (%) | 5.12% |
Shares Floating | 1.04M |
Failed to Deliver (FTD) Shares | 12.07K |
FTD / Avg. Volume | 13.75% |
Short Selling Information
Short Interest | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is -50.98 and the forward PE ratio is null. Virios Therapeutics's PEG ratio is 0.68.
PE Ratio | -50.98 |
Forward PE | n/a |
PS Ratio | 0 |
Forward PS | null |
PB Ratio | 70.92 |
P/FCF Ratio | -55.44 |
PEG Ratio | 0.68 |
Enterprise Valuation
Virios Therapeutics has an Enterprise Value (EV) of 266.68M.
EV / Sales | 0 |
EV / EBITDA | 1767.23 |
EV / EBIT | -54.75 |
EV / FCF | -54.75 |
Financial Position
The company has a current ratio of 11.62, with a Debt / Equity ratio of 0.
Current Ratio | 11.62 |
Quick Ratio | 11.62 |
Debt / Equity | 0 |
Debt / EBITDA | 0 |
Debt / FCF | 0 |
Interest Coverage | 0 |
Financial Efficiency
Return on Equity is -139.12% and Return on Invested Capital is -142.93%.
Return on Equity | -139.12% |
Return on Assets | -127.14% |
Return on Invested Capital | -142.93% |
Revenue Per Employee | $0 |
Profits Per Employee | $-1.32M |
Employee Count | 4 |
Asset Turnover | 0 |
Inventory Turnover | n/a |
Taxes
Income Tax | -5.45K |
Effective Tax Rate | 0.1% |
Stock Price Statistics
The stock price has increased by -98.59% in the last 52 weeks. The beta is 1.58, so Virios Therapeutics's price volatility has been higher than the market average.
Beta | 1.58 |
52-Week Price Change | -98.59% |
50-Day Moving Average | 4.41 |
200-Day Moving Average | 7.21 |
Relative Strength Index (RSI) | 51.55 |
Average Volume (20 Days) | 87.79K |
Income Statement
Revenue | n/a |
Gross Profit | 0 |
Operating Income | -5.45M |
Net Income | -5.3M |
EBITDA | 150.9K |
EBIT | n/a |
Earnings Per Share (EPS) | -0.28 |
Balance Sheet
The company has 3.32M in cash and 0 in debt, giving a net cash position of 3.32M.
Cash & Cash Equivalents | 3.32M |
Total Debt | 0 |
Net Cash | 3.32M |
Retained Earnings | -61.47M |
Total Assets | 3.64M |
Working Capital | 3.14M |
Cash Flow
In the last 12 months, operating cash flow was -4.87M and capital expenditures 0, giving a free cash flow of -4.87M.
Operating Cash Flow | -4.87M |
Capital Expenditures | 0 |
Free Cash Flow | -4.87M |
FCF Per Share | -0.26 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
VIRI does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | -1.96% |
FCF Yield | -1.8% |
Analyst Forecast
The average price target for VIRI is $15, which is 9900% higher than the current price. The consensus rating is "Hold".
Price Target | $15 |
Price Target Difference | 9900% |
Analyst Consensus | Hold |
Analyst Count | 2 |
Scores
Altman Z-Score | -29.81 |
Piotroski F-Score | 1 |